Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263679
Status:
COMPLETED
Last Update Posted:
2016-09-15
First Post:
2005-12-08
Brief Title:
Assessment of GSK Biologicals Tdap Candidate Vaccine Administered as a Booster 6th Dose in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine
Sponsor:
Organization:
GlaxoSmithKline